Stay updated with breaking news from World Duchenne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Santhera’s AGAMREE (Vamorolone) Approved in the European Union for the Treatment of Duchenne Muscular Dystrophy
European Commission (EC) grants marketing authorization for AGAMREE® for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and olderAGAMREE® is the only approved medication in the European Union (EU) for treating DMD, and the first DMD treatment approved in both the U.S. and EUFirst commercial launch of AGAMREE®, in Germany, expected in Q1-2024 EMA acknowledges safety benefits of AGAMREE® with regards to preserving bone health and maintaining growth compared to standard
18.12.2023 - European Commission (EC) grants marketing authorization for AGAMREE for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and olderAGAMREE is the only approved medication in the European Union (EU) for treating DMD, and the ... Seite 1
On Sept. 7, the Deming community gathered at the Luna County Courthouse park to commemorate World Duchenne Awareness Day. Attendees were encouraged to wear red to show their support. Duchenne and Becker muscular dystrophy (DMD) are rare genetic diseases that cause progressive muscle breakdown. Caused by a mutation of the X-chromosome, it affects young males predominantly, according to the event’s information flier. The event was organized by Family, Friends, and …
A charity campaigner and a senior police officer are among those who have been recognised in the King’s first Birthday Honours List.